Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

被引:166
作者
Koletzko, S.
Richy, F.
Bontems, P.
Crone, J.
Kalach, N.
Monteiro, M. L.
Gottrand, F.
Celinska-Cedro, D.
Roma-Giannikou, E.
Orderda, G.
Kolacek, S.
Urruzuno, P.
Martinez-Gomez, M. J.
Casswall, T.
Ashorn, M.
Bodanszky, H.
Megraud, F.
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
[2] Univ Bordeaux 2, INSERM, ERI 10, F-33076 Bordeaux, France
[3] Queen Fabiola Childrens Hosp, Brussels, Belgium
[4] Univ Vienna, A-1010 Vienna, Austria
[5] Hop Cochin, F-75674 Paris, France
[6] Inst Nacl Saude Dr Ricardo, Lisbon, Portugal
[7] Hop J Flandre, Lille, France
[8] Childrens Inst, Warsaw, Poland
[9] Univ Athens, Dept Paediat 1, Athens, Greece
[10] Univ Piemonte Orientale, Novara, Italy
[11] Univ Zagreb, Childrens Hosp, Zagreb, Croatia
[12] Hosp 12 Octubre, E-28041 Madrid, Spain
[13] Hosp Nino Jesus, Madrid, Spain
[14] Karolinska Univ Hosp, Stockholm, Sweden
[15] Univ Tampere, FIN-33101 Tampere, Finland
[16] Semmelweis Univ, H-1085 Budapest, Hungary
关键词
D O I
10.1136/gut.2006.091272
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To prospectively assess the antibacterial resistance rate in Helicobacter pylori strains obtained from symptomatic children in Europe. Methods: During a 4-year period, 17 paediatric centres from 14 European countries reported prospectively on patients infected with H pylori, for whom antibiotic susceptibility was tested. Results: A total of 1233 patients were reported from Northern (3%), Western (70%), Eastern (9%) and Southern Europe (18%); 41% originated from outside Europe as indicated by mother's birth-country; 13% were,6 years of age, 43% 6 - 11 years of age and 44% > 11 years of age. Testing was carried out before the first treatment (group A, n = 1037), and after treatment failure (group B, n = 196). Overall resistance to clarithromycin was detected in 24% (mean, A: 20%, B: 42%). The primary clarithromycin resistance rate was higher in boys (odds ratio (OR) 1.58; 1.12 to 2.24, p = 0.01), in children,6 years compared with > 12 years (OR 1.82, 1.10 to 3.03, p = 0.020) and in patients living in Southern Europe compared with those living in Northern Europe (OR 2.25; 1.52 to 3.30, p < 0.001). Overall resistance rate to metronidazole was 25% (A: 23%, B: 35%) and higher in children born outside Europe (A: adjusted. OR 2.42, 95% CI: 1.61 to 3.66, p < 0.001). Resistance to both antibiotics occurred in 6.9% (A: 5.3%, B: 15.3%). Resistance to amoxicillin was exceptional (0.6%). Children with peptic ulcer disease (80/1180, 6.8%) were older than patients without ulcer (p = 0.001). Conclusion: The primary resistance rate of H pylori strains obtained from unselected children in Europe is high. The use of antibiotics for other indications seems to be the major risk factor for development of primary resistance.
引用
收藏
页码:1711 / 1716
页数:6
相关论文
共 25 条
  • [1] Clarithromycin resistance among Helicobacter pylori strains isolated from children:: Prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis
    Alarcón, T
    Vega, AE
    Domingo, D
    Martínez, MJ
    López-Brea, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) : 486 - 488
  • [2] Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children
    Bontems, P
    Devaster, JM
    Corvaglia, L
    Dezsöfi, A
    van den Borre, C
    Goutier, S
    Butzler, JP
    Cadranel, S
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (11) : 1033 - 1038
  • [3] Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)
    Cabrita, J
    Oleastro, M
    Matos, R
    Manhente, A
    Cabral, J
    Barros, R
    Lopes, AI
    Ramalho, P
    Neves, BC
    Guerreiro, AS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1029 - 1031
  • [4] Helicobacter pylori in children and adolescents:: Increase of primary clarithromycin resistance, 1997-2000
    Crone, J
    Granditsch, G
    Huber, WD
    Binder, C
    Innerhofer, A
    Amann, G
    Hirschl, AM
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 36 (03) : 368 - 371
  • [5] Drumm Brendan, 2000, JPGN, V30, P207, DOI 10.1097/00005176-200002000-00020
  • [6] Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States
    Duck, WM
    Sobel, J
    Pruckler, JM
    Song, OS
    Swerdlow, D
    Friedman, C
    Sulka, A
    Swaminathan, B
    Taylor, T
    Hoekstra, M
    Griffin, P
    Smoot, D
    Peek, R
    Metz, DC
    Bloom, PB
    Goldschmid, S
    Parsonnet, J
    Triadafilopoulos, G
    Perez-Perez, GI
    Vakil, N
    Ernst, P
    Czinn, S
    Dunne, D
    Gold, BD
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (06) : 1088 - 1094
  • [7] European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori
    Glupczynski, Y
    Mégraud, F
    Lopez-Brea, M
    Andersen, LP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (11) : 820 - 823
  • [8] Helicobacter pylori infection in children:: Recommendations for diagnosis and treatment
    Gold, BD
    Colletti, RB
    Abbott, M
    Czinn, SJ
    Elitsur, Y
    Hassall, E
    Macarthur, C
    Snyder, J
    Sherman, PM
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (05) : 490 - 497
  • [9] Canadian Helicobacter Study Group Consensus Conference:: Update on the approach to Helicobacter pylori infection in children and adolescents -: An evidence-based evaluation
    Jones, NL
    Sherman, P
    Fallone, CA
    Flook, N
    Smaill, F
    van Zanten, SV
    Hunt, R
    Thomson, A
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2005, 19 (07): : 399 - 408
  • [10] Clarithromycin resistance and eradication of Helicobacter pylori in children
    Kalach, N
    Benhamou, PH
    Campeotto, F
    Bergeret, M
    Dupont, C
    Raymond, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2134 - 2135